Internal Medicine, Endocrinology, Diabetes, & Metabolism · Los Angeles, CA
NPI
1447593207
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1200 N State St
Los Angeles, CA, 90033
Phone (323) 226-7556
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,251
26 services
Medicare patients, 2024
17
Average age 60
Drug cost, 2024
$678K
2,646 prescriptions
Company payments, 2025
$104
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel de Moss was code 99214 (office e&m - established), 17 times for 11 patients. In total Daniel de Moss billed 26 services in 7 codes, and Medicare paid $2,251.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 17 | 11 | $95.30 | $1,620 |
By year: 2022 $2,796 for 33 services; 2023 $2,095 for 31 services; 2024 $2,251 for 26 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel de Moss prescribed most often to Medicare patients was Levothyroxine Sodium, with 534 prescriptions and refills. In total Daniel de Moss wrote 2,646 Medicare prescriptions that cost $678K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 534 | 1,720 | 168 | $11K |
| Ozempic Semaglutide | 206 | 233 | 45 | $164K |
| Methimazole Generic | 173 | 569 | 61 | $3,383 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 142 | 424 | 69 | $4,971 |
| Insulin Glargine-Yfgn Generic | 113 | 309 | 50 | $14K |
| Alendronate Sodium Generic | 91 | 252 | 37 | $892 |
| Humalog Kwikpen U-100 Insulin Lispro | 86 | 231 | 41 | $27K |
| Jardiance Empagliflozin | 81 | 269 | 35 | $52K |
| Testosterone Generic | 76 | 220 | 31 | $10K |
| Spironolactone Generic | 67 | 223 | 24 | $1,626 |
| Forteo Teriparatide | 57 | 59 | Under 11 | $79K |
| Humalog Insulin Lispro | 54 | 159 | 24 | $15K |
| Metformin Hcl Generic | 50 | 165 | 20 | $641 |
| Hydrocortisone Generic | 47 | 148 | 18 | $3,383 |
| Testosterone Cypionate Generic | 37 | 98 | 12 | $3,035 |
Brand drugs: 946 claims; generic drugs: 1,494 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel de Moss $104 ($104 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $42.46.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.